Prevention of osteoporosis: Paradigm oestrogen substitution;Osteoporoseprävention: Paradigma Östrogensubstitution

Gesundheitswesen

Volumn 58, Issue 2, 1996, Pages 111-114

  Lange, S ^a   Paesler, Ellen ^a   Richter, K ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Bias; Estrogen replacement therapy; Hip fractures; Osteoporosis

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EPIDEMIOLOGY; ESTROGEN THERAPY; FEMALE; HIP FRACTURE; HUMAN; META ANALYSIS; MIDDLE AGED; PATHOLOGIC FRACTURE; POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; STATISTICS; TREATMENT OUTCOME;

BIAS (EPIDEMIOLOGY); ESTROGEN REPLACEMENT THERAPY; FEMALE; FRACTURES, SPONTANEOUS; HIP FRACTURES; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0030075052     PISSN: 09413790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Avioli, L. V.: Significance of osteoporosis: a growing international health care problem. Calcif. Tissue Int. 49 (1991) S5-S7
2. Cauley, J. A., D. G. Seeley. K. Ensrud, B. Ettinger, D. Black. S. R. Cummings: Estrogen replacement therapy and fractures in older women. Ann. Intern. Med. 122 (1995) 9-16
3. Colditz, G. A., S. E. Hankinson, D. J. Hunter. W. C. Willett J. E. Manson, M. J. Stampfer, C. Hennekens, B. Rosner, F. E. Speizer: The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N. Engl. J. Med. 332 (1995) 1590-1593
4. Consensus Development Conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am. J. Med. 94 (1993) 646-650
5. Cummings. S. R., M, C. Nevitt, W. S. Browner. K. Stone, K. M. Fox, K. E. Ensrud, J. Cauley, D. Black, T. M. Vogt: Risk factors for hip fracture in white women. N. Engl. J. Med. 332 (1995) 767-773
6. Ettinger, B., H. K. Genant, C. E. Cann: Long-term estrogen replacement therapy prevents bone loss and fractures. Ann. Intern. Med. 102 (1985) 319-324
7. Ettinger, B., D. Grady: The waning effect of postemenopausal estrogen therapy on osteoporosis. N. Engl. J. Med. 329 (1993) 1192-1193
8. Grady, D., S. M. Rubin, D. B. Petitti, C. S. Fox, D. Black, B. Ettinger, V. L. Ernster, S. R. Cummings: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. 117 (1992) 1016-1037
9. Grisso, J. A., J. L. Kelsey, B. L. Strom, L. A. O'Brien, G. Maislin, K. LaPann, L. Samelson, S. Huffman: Risk factors for hip fracture in black women. N. Engl. J. Med. 330 (1994) 1555-1559
10. Hemminki, E., M. Malin, P. Topo: Selection to postmenopausal therapy by women's characteristics. J. Clin. Epidemiol. 46 (1993) 211-219
11. Hemminki, E., S. Sihvo: A review of postmenopausal hormone therapy recommendations: potential for selection bias. Obstet. Gynecol. 82 (1993) 1021-1028
12. Holbrook, T. L., E. Barrett-Connor, D. L. Wingard: Dietary Calcium and risk of hip fracture: 14-year prospective study. Lancet ii (1988) 1046-1049